OccamzRazor

United States
Troy, New Hampshire, United States, 10013

Company profile

OccamzRazor company profile

OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.) and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
10013
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
6
Total equity funding
$11.7M
Last funding
Series A / $6.1M / 2022-03-08
Last equity funding
Series A / $6.1M
Investors
16
Lead investors
1
Founders
3
Articles
2

Founders and investors

Founders

Katharina Sophia VolzKaya TilevMartin Bringmann

Lead investors

Jeff Dean

Investors

Human CapitalJeff DeanMichael J. Fox FoundationPositive VenturesValor Equity Partners